Thomas Smith
Stock Analyst at Leerink Partners
(1.3)
# 1829
Out of 5,372 analysts
103
Total ratings
30.51%
Success rate
17.36%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
EQ Equillium | Downgrades: Market Perform | 3 1 | n/a | n/a | 4 | Mar 28, 2025 | |
QTTB Q32 Bio | Downgrades: Market Perform | 68 9 | 1.61 | 459.01% | 2 | Dec 11, 2024 | |
ACRS Aclaris Therapeutics | Upgrades: Outperform | 2 7 | 1.41 | 396.45% | 7 | Nov 19, 2024 | |
ALMS Alumis | Initiates Coverage On: Outperform | 29 | 3.02 | 860.26% | 1 | Jul 23, 2024 | |
RNAC Cartesian Therapeuti... | Initiates Coverage On: Outperform | 39 | 9.8 | 297.96% | 1 | Apr 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 42 65 | n/a | n/a | 2 | Apr 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 26 | 6.88 | 277.91% | 1 | Mar 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 80 | 7.82 | 923.02% | 2 | Feb 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 33 | n/a | n/a | 2 | Feb 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 20 | 6.05 | 230.58% | 1 | Nov 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 30 17 | n/a | n/a | 3 | May 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 45 56 | n/a | n/a | 1 | Mar 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 430 435 | 540.53 | -19.52% | 3 | Mar 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 17 18 | n/a | n/a | 7 | Mar 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 36 | 50.14 | -28.2% | 1 | Feb 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 7 | 1.06 | 560.38% | 4 | Feb 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 14 21 | 15.29 | 37.34% | 6 | Feb 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 45 | 14.88 | 202.42% | 2 | Jan 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 6 | 6.13 | -2.12% | 1 | Nov 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 16 19 | n/a | n/a | 2 | Nov 21, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 30 20 | n/a | n/a | 4 | Nov 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 5 6 | 3.75 | 60% | 2 | Nov 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 9 5 | 0.77 | 549.35% | 3 | Oct 21, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 46 77 | n/a | n/a | 1 | Oct 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 17 | 43.05 | -60.51% | 1 | Aug 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 55 60 | n/a | n/a | 5 | Aug 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 68 64 | 20.07 | 218.88% | 2 | Aug 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 66 70 | 17.73 | 294.81% | 5 | Aug 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 225 150 | n/a | n/a | 5 | Aug 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 29 | 9.94 | 191.75% | 5 | Jul 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 33 26 | 2.81 | 825.27% | 3 | Jun 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 13 12 | n/a | n/a | 4 | May 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 12 | 26.45 | -54.63% | 2 | Apr 28, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 10 | 4.13 | 142.13% | 4 | Apr 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 675 400 | 3.16 | 12558.23% | 2 | Mar 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 80 | 13.48 | 493.47% | 2 | Dec 8, 2020 |